• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT MITRACLIP SYSTEM STEERABLE GUIDE CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT MITRACLIP SYSTEM STEERABLE GUIDE CATHETER Back to Search Results
Catalog Number SGC0302
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fistula (1862); Hemorrhage/Bleeding (1888); Pseudoaneurysm (2605)
Event Date 03/22/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The customer reported the device was discarded.Investigation is not yet complete.A follow up report will be submitted with all relevant information.
 
Event Description
This is filed to report the access site fistula and pseudo-aneurysm.It was reported that 0n (b)(6) 2018, the patient underwent a mitraclip procedure, with implantation of one clip, reducing the functional mitral regurgitation (mr) from grade 3 to less than 1.An arteriovenous fistula and pseudoaneurysm developed at the femoral venous puncture site, leading to a drop in serum free hemoglobin.A transfusion of packed red blood cells was performed and a vascular endoprosthesis stent was deployed in the superficial right femoral artery to seal the leakages.The patient effect resolved on (b)(6) 2018.No additional information was provided.
 
Manufacturer Narrative
(b)(4).The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot.The reported patient effects of arterio-venous fistula and hemmorhage requiring transfusion as listed in the mitraclip system instructions for use are known possible complications associated with mitraclip procedures.Based on the information reviewed, the reported patient effect of fistula appears to be related to procedural conditions.The reported patient effect of hemmorhage appears to be a secondary effect of the fistula.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Manufacturer Narrative
(b)(4).The reported patient effect of psuedoaneurysm as listed in the mitraclip system instructions for use is a known possible complications associated with mitraclip procedures.Based on the information reviewed, the reported patient effect of psuedoaneurysm appears to be related to procedural conditions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM STEERABLE GUIDE CATHETER
Type of Device
STEERABLE GUIDE CATHETER
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key7535159
MDR Text Key108978511
Report Number2024168-2018-03824
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
PMA/PMN Number
K161985
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Other
Type of Report Initial,Followup,Followup
Report Date 02/26/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/22/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/18/2019
Device Catalogue NumberSGC0302
Device Lot Number80117U102
Was Device Available for Evaluation? No
Date Manufacturer Received02/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ASPIRIN, CLOPIDOGRELIMPLANTED MITRACLIP (X1)
Patient Outcome(s) Required Intervention;
Patient Age69 YR
Patient Weight83
-
-